Dr AvinashTank, is a super-specialist (MCh) Laparoscopic Gastro-intestinal Surgeon,

SwasthyaCON 2025 Highlights the Role of Endocrine Disruptors in Diabetes and Obesity

  • Home
  • -
  • News
  • -
  • SwasthyaCON 2025 Highlights the Role of Endocrine Disruptors in Diabetes and Obesity
SwasthyaCON 2025 Highlights the Role of Endocrine Disruptors in Diabetes and Obesity

SwasthyaCON 2025 Highlights the Role of Endocrine Disruptors in Diabetes and Obesity.

Ahmedabad, January 2025 – SwasthyaCON 2025, a premier medical conference organized by Dr. Mayur Patel, a renowned senior diabetologist, shed light on the pressing issue of endocrine-disrupting chemicals (EDCs) and their role in the increasing prevalence of diabetes and obesity.

One of the key sessions focused on the harmful effects of EDCs, presented by leading endocrinologists and experts in metabolic disorders. The session detailed the pervasive nature of these chemicals, which are found in natural and synthetic hormones, pesticides, industrial by-products, plastics, and other consumer products.

Endocrine Disruptors: A Growing Threat

Endocrine-disrupting chemicals are exogenous substances or mixtures that interfere with the normal functioning of the endocrine system, resulting in adverse health effects on individuals and populations.

The presentation highlighted how EDCs, such as bisphenol A, phthalates, and dioxins, mimic or block hormones like estrogens and androgens.

The session provided a detailed classification of EDCs, including:

Estrogens: DES, bisphenol A, DEHP

Anti-estrogens: Hexachloro-4-biphenylol, luteolin

Anti-androgens: DDE, vinclozolin

Adrenal toxins: Glycyrrhizic acid

Metals: Cadmium, nickel, aluminum

These chemicals are omnipresent in the environment, making exposure nearly unavoidable for humans and wildlife alike.

Link to Diabetes and Obesity

The presentation emphasized the role of EDCs in disrupting glucose metabolism and increasing adipogenesis, leading to insulin resistance, type 2 diabetes, and obesity. Evidence suggests that chronic exposure to EDCs during critical periods of development (e.g., fetal or childhood stages) can predispose individuals to metabolic diseases later in life.

Preventive Approaches

The speakers outlined strategies to reduce EDC exposure and mitigate their effects:

1. Public Awareness: Educating individuals about the sources of EDCs in everyday products such as plastics, food packaging, and pesticides.

2. Policy Changes: Advocating for stricter regulations on the use of harmful chemicals in consumer products.

3. Lifestyle Modifications: Encouraging the use of organic food, glass or stainless-steel containers, and safer personal care products.

4. Early Screening: Identifying individuals at risk through metabolic screening and monitoring.

Call to Action

The session concluded with a call for collaborative efforts between healthcare providers, policymakers, and researchers to combat the growing epidemic of diabetes and obesity through awareness, prevention, and innovative therapeutic strategies.

SwasthyaCON 2025 continues to pave the way for impactful discussions on advancing therapeutic solutions from innovation to implementation.

Translate »
error: Content is protected !!

Book An Appointment

Consult Online

Name(Required)